Armodafinil Market
Armodafinil Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Armodafinil Market Size and Growth
The Armodafinil market is experiencing robust growth, driven by increasing demand for cognitive enhancers and sleep disorder treatments. The global market size was valued at approximately $1.5 billion in 2023, with a projected CAGR of 7% through 2030. Competitive dynamics are shifting due to emerging alternatives and regulatory developments.
Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Teva
◍ Mylan
◍ Apotex
◍ Lupin
◍ Sandoz
◍ Natco Pharma
◍ Aurobindo
The Armodafinil market features key players like Teva, Mylan, Apotex, Lupin, Sandoz, Natco Pharma, and Aurobindo. These companies drive growth through extensive product availability, competitive pricing, and strategic partnerships. Notable sales revenues include:
- Teva: $16 billion
- Mylan: $11 billion
- Lupin: $2.4 billion. Request Sample Report
Market Segmentation
By Application
◍ Obstructive Sleep Apnea (OSA) and Narcolepsy
◍ Shift Work Disorder (SWD)
◍ Patients with Severe Hepatic Impairment
◍ Geriatric Patients
By Product
◍ 50 mg Tablets
◍ 150 mg Tablets ◍ 200 mg Tablets ◍ 250 mg Tablets
Request Sample Report
Market Growth
Request Sample Report
$ 1.52 Billion
